Lucintel Forecasts The Global Ndds Cancer Therapy Market To Grow With A Cagr Of 17.2% From 2025 To 2031

By Author: Lucintel LLC
Total Articles: 6340
Comment this article

According to a market report by Lucintel, the future of the global NDDS cancer therapy market looks promising with opportunities in the hospital and clinic markets. The global NDDS cancer therapy market is expected to grow with a CAGR of 17.2% from 2025 to 2031. The major drivers for this market are the increasing cancer incidence and demand for targeted therapy and the enhanced drug solubility & bioavailability.
A more than 150-page report to understand trends, opportunity and forecast in global NDDS cancer therapy market to 2031 by type (liquid embolic, embolization particle, and nanoparticles), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, liquid embolic agents will remain the largest segment over the forecast period due to wider application in clinical settings.
Within the application category, hospitals is expected to witness the higher growth due to complex & advanced treatments.
Download sample by clicking on NDDS cancer therapy market.
In terms of region, ...
... North America is expected to witness the highest growth over the forecast period.
Advanced Medical Isotope Corporation, Boston Scientific Corporation, CeloNova Biosciences, Cook Medical, Cospheric LLC are the major suppliers in the NDDS cancer therapy market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Flow Cytometry Tube Holder Market
Flow Cytometry Fluorophore Market
Flow Cytometry Compensation Bead Market
Flow Cytometry Antibody Reagent Market
Flow Cup Meter Market